Category
|
1
|
2
|
3
|
4
|
---|
AUS
|
-
|
-
|
+
|
+
|
18F-FDG-uptake
|
-
|
+
|
-
|
+
|
No. of involved ALNs
| | | | |
0
|
117 (85)
|
6 (50)
|
1 (20)
|
0 (0)
|
1
|
12 (9)
|
5 (42)
|
2 (40)
|
9 (32)
|
2 ≦ Involved ALNs ≦ 5 |
6 (4)
|
1 (8)
|
1 (20)
|
9 (32)
|
6 ≦ |
3 (2)
|
0 (0)
|
1 (20)
|
10 (36)
|
The maximum size of involved ALNs
| | | | |
≦ 5 mm |
10(48)
|
5 (83)
|
0 (0)
|
0 (0)
|
5 mm < metastasis < 10 mm
|
7(33)
|
1 (17)
|
2 (50)
|
6 (21)
|
10 mm ≦ |
4(19)
|
0 (0)
|
2 (50)
|
22(79)
|
Nuclear grade of involved ALNs
| | | | |
Grade 1 and 2
|
16(76)
|
3 (50)
|
4 (100)
|
13(46)
|
Grade 3
|
5(24)
|
3 (50)
|
0 (0)
|
15(54)
|
Frequency of involved ALNs
|
15%
|
50%
|
80%
|
100%
|
Indications of ALND/PSC
|
SNB
|
FNAC/Bx is needed
|
FNAC/Bx is needed
|
Acceptable
|
Total
|
138 (100)
|
12 (100)
|
5 (100)
|
28 (100)
|
- AUS, Axillary ultrasound; ALN, Axillary lymph node; ALND, ALN dissection; PSC, Primary systemic chemotherapy; No., Number; pts, patients; FNAC, Fine needle aspiration